IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Trails Edge Capital Partners, LP

Q1 2026 Holdings

Filed 2026-05-15 | 27 holdings | $436.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$38.5M662,4708.8%
Definium Therapeutics Inc(DFTX)COM SHS24477V105$32.9M1,738,1107.5%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$32.5M1,319,3627.5%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$30.8M333,3127.1%
Nurix Therapeutics Inc(NRIX)COM67080M103$27.0M1,743,2206.2%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$25.6M440,0005.9%
Revolution Medicines Inc(RVMD)COM76155X100$23.8M245,0005.5%
Arcus Biosciences Inc(RCUS)COM03969F109$22.6M1,047,9355.2%
Immunocore Hldgs PLC(IMCR)ADS45258D105$20.6M682,5974.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$19.8M300,0004.5%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$16.4M701,8213.8%
Neurogene Inc(NGNE)COM64135M105$15.8M782,7873.6%
Inventiva SA(IVA)ADS46124U107$14.8M2,657,9973.4%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$13.5M8,057,3453.1%
4D Molecular Therapeutics in(FDMT)COM35104E100$12.1M1,302,9172.8%
Xenon Pharmaceuticals Inc(XENE)PutCOM98420N105$11.6M200,0002.7%
X4 Pharmaceuticals Inc(XFOR)COM NEW98420X202$10.6M2,571,4782.4%
Immunovant Inc(IMVT)COM45258J102$10.3M414,0542.4%
Design Therapeutics Inc(DSGN)COM25056L103$9.1M852,0132.1%
Camp4 Therapeutics Corp(CAMP)COM13463J101$8.6M1,939,5632.0%
Minerva Neurosciences Inc(NERV)COM NEW603380205$8.5M1,419,0002.0%
Promis Neurosciences Inc(PMN)COM SHS74346M505$7.1M557,1031.6%
Sol-Gel Technologies LTD(SLGL)SHS NEWM8694L137$6.8M85,4961.6%
Century Therapeutics Inc(IPSC)COM15673T100$5.5M2,449,9931.3%
VTV Therapeutics Inc(VTVT)CL A NEW918385204$5.5M139,5781.3%
Sensei Biotherapeutics Inc(SNSE)COM NEW81728A207$3.9M125,0000.9%
Opus Genetics Inc(IRD)COM67577R102$2.3M500,0000.5%